143
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A retrospective study of non-ventilator hospital-acquired pneumonia in a Norwegian hospital: a serious medical condition in need of better and timelier microbiological diagnostics

, , , &
Received 29 Dec 2023, Accepted 15 Jun 2024, Published online: 26 Jun 2024

References

  • Suetens C, Latour K, Kärki T, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23(46):1800516 doi: 10.2807/1560-7917.ES.2018.23.46.1800516.
  • Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198–1208. doi: 10.1056/NEJMoa1306801.
  • Giuliano KK, Baker D, Quinn B. The epidemiology of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control. 2018;46(3):322–327. doi: 10.1016/j.ajic.2017.09.005.
  • Quinn B, Baker DL, Cohen S, et al. Basic nursing care to prevent nonventilator hospital-acquired pneumonia. J Nurs Scholarsh. 2014;46(1):11–19. doi: 10.1111/jnu.12050.
  • Sopena N, Sabria M, Neunos 2000 Study Group. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest. 2005;127(1):213–219. doi: 10.1378/chest.127.1.213.
  • Ji W, McKenna C, Ochoa A, et al. Development and assessment of objective surveillance definitions for nonventilator hospital-acquired pneumonia. JAMA Netw Open. 2019;2(10):e1913674. doi: 10.1001/jamanetworkopen.2019.13674.
  • Jones BE, Sarvet AL, Ying J, et al. Incidence and outcomes of non-ventilator-associated hospital-acquired pneumonia in 284 US hospitals using electronic surveillance criteria. JAMA Netw Open. 2023;6(5):e2314185. doi: 10.1001/jamanetworkopen.2023.14185.
  • Kalil AC, Metersky ML, Klompas M, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111. doi: 10.1093/cid/ciw353.
  • Centers for Disease Control and Prevention. Pneumonia events – Ventilator-associated and non-ventilator-associated Penumonia (PNEU); 2021. Available from: https://www.cdc.gov/nhsn/psc/pneu/index.html.
  • Davis J. A second breadth: hospital-acquired pneumonia in pennsylvania nonventilated versus ventilated patients. PA Patient Saf Advis. 2018;15(3):1–12.
  • Micek ST, Chew B, Hampton N, et al. A case-control study assessing the impact of nonventilated hospital-acquired pneumonia on patient outcomes. Chest. 2016;150(5):1008–1014. doi: 10.1016/j.chest.2016.04.009.
  • See I, Chang J, Gualandi N, et al. Clinical correlates of surveillance events detected by National Healthcare Safety Network Pneumonia and Lower Respiratory Infection Definitions-Pennsylvania, 2011–2012. Infect Control Hosp Epidemiol. 2016;37(7):818–824. doi: 10.1017/ice.2016.74.
  • Sopena N, Heras E, Casas I, et al. Risk factors for hospital-acquired pneumonia outside the intensive care unit: a case-control study. Am J Infect Control. 2014;42(1):38–42. doi: 10.1016/j.ajic.2013.06.021.
  • Cassini A, Plachouras D, Eckmanns T, et al. Burden of six healthcare-associated infections on European population health: estimating incidence-based disability-adjusted life years through a population prevalence-based modelling study. PLoS Med. 2016;13(10):e1002150. doi: 10.1371/journal.pmed.1002150.
  • Kalsekar I, Amsden J, Kothari S, et al. Economic and utilization burden of hospital-acquired pneumonia (HAP): A systematic review and meta-analysis. Chest. 2010;138(4):739A. doi: 10.1378/chest.10337.
  • Munro SC, Baker D, Giuliano KK, et al. Nonventilator hospital-acquired pneumonia: A call to action. Infect Control Hosp Epidemiol. 2021;42(8):991–996. doi: 10.1017/ice.2021.239.
  • Rodrigo-Troyano A, Sibila O. The respiratory threat posed by multidrug resistant gram-negative bacteria. Respirology. 2017;22(7):1288–1299. doi: 10.1111/resp.13115.
  • Esperatti M, Ferrer M, Giunta V, et al. Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU. Crit Care Med. 2013;41(9):2151–2161. doi: 10.1097/CCM.0b013e31828a674a.
  • Gross AE, Schooneveld TCV, Olsen KM, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother. 2014;58(9):5262–5268. doi: 10.1128/AAC.02582-14.
  • Ibrahim EH, Ward S, Sherman G, et al. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest. 2000;117(5):1434–1442. doi: 10.1378/chest.117.5.1434.
  • Vallés J, Martin-Loeches I, Torres A, et al. Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study. Intensive Care Med. 2014;40(4):572–581. doi: 10.1007/s00134-014-3239-2.
  • Gray S, Lambrelli D, Eriksson D, et al. Incidence of hospitalized all-cause pneumonia, and serotype distribution of hospitalized Streptococcus pneumoniae pneumonia in Norway 2008–2009. Eur Respir J. 2013;42(Suppl 57):P4204.
  • National Centre for Disease Control, Directorate General of Health Services. National guideline for the use of antibiotics in hospitals (2013–2020); 2018.
  • Claessens YE, Debray M-P, Tubach F, et al. Early chest computed tomography scan to assist diagnosis and guide treatment decision for suspected community-acquired pneumonia. Am J Respir Crit Care Med. 2015;192(8):974–982. doi: 10.1164/rccm.201501-0017OC.
  • Esayag Y, Nikitin I, Bar-Ziv J, et al. Diagnostic value of chest radiographs in bedridden patients suspected of having pneumonia. Am J Med. 2010;123(1):88 e1-5. doi: 10.1016/j.amjmed.2009.09.012.
  • Hayden GE, Wrenn KW. Chest radiograph vs. computed tomography scan in the evaluation for pneumonia. J Emerg Med. 2009;36(3):266–270. doi: 10.1016/j.jemermed.2007.11.042.
  • Syrjala H, Broas M, Suramo I, et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis. 1998;27(2):358–363. doi: 10.1086/514675.
  • Corradi F, Brusasco C, Garlaschi A, et al. Quantitative analysis of lung ultrasonography for the detection of community-acquired pneumonia: a pilot study. Biomed Res Int. 2015;2015:868707. doi: 10.1155/2015/868707.
  • Liu XL, Lian R, Tao Y, et al. Lung ultrasonography: an effective way to diagnose community-acquired pneumonia. Emerg Med J. 2015;32(6):433–438. doi: 10.1136/emermed-2013-203039.
  • Quinn B, Giuliano KK, Baker D. Non-ventilator health care-associated pneumonia (NV-HAP): best practices for prevention of NV-HAP. Am J Infect Control. 2020;48(5S):A23–A27. doi: 10.1016/j.ajic.2020.03.006.
  • Vignari M. Non-ventilator health care-associated pneumonia (NV-HAP): NV-HAP risk factors. Am J Infect Control. 2020;48(5S):A10–A13. doi: 10.1016/j.ajic.2020.03.010.
  • NORM/NORM-VET. NORM/NORM-VET 2018. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway; 2019.
  • NORM/NORM-VET. NORM/NORM-VET 2017. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway; 2018.
  • NORM/NORM-VET. NORM/NORM-VET 2008. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway; 2009.
  • NORM/NORM-VET. NORM/NORM-VET 2015. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway; 2016.